Comparative safety analysis of antiinterleukin-4/interleukin-13 inhibitors and Janus Kinase inhibitors in atopic dermatitis

被引：0
|
作者：
Bao, Aaron [1 ]
Su, Hsing-Jou [1 ]
Wan, Joy [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, 200 N Wolfe St,Suite 2107, Baltimore, MD 21287 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jaad.2024.06.064
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：768 / 771
页数：4
相关论文
共 50 条
  • [21] Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: Military Considerations
    Nolan, Colin F.
    [J]. CUTIS, 2022, 110 (06): : 316 - 320
  • [22] Efficacy of Janus kinase inhibitors in the treatment of psoriasiform atopic dermatitis
    Napolitano, Maddalena
    Foggia, Luciano
    Patruno, Cataldo
    Gallo, Lucia
    Tommasino, Nello
    Cecere, Daniele
    Megna, Matteo
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1232 - 1234
  • [23] Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
    Singh, Rhea
    Heron, Courtney E.
    Ghamrawi, Rima, I
    Strowd, Lindsay C.
    Feldman, Steven R.
    [J]. IMMUNOTARGETS AND THERAPY, 2020, 9 : 255 - 272
  • [24] Janus kinase inhibitors for atopic dermatitis: a promising treatment modality
    Cartron, A. M.
    Nguyen, T. H.
    Roh, Y. S.
    Kwatra, M. M.
    Kwatra, S. G.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 820 - 824
  • [25] Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis
    Zhang, Lu
    Du, Dan
    Wang, Lian
    Guo, Linghong
    Jiang, Xian
    [J]. JOURNAL OF DERMATOLOGY, 2021, 48 (12): : 1877 - 1883
  • [26] Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
    Sedeh, Farnam B.
    Henning, Mattias A. S.
    Jemec, Gregor B. E.
    Ibler, Kristina S.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [27] The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
    Yoon, Sanghyuk
    Kim, Kihun
    Shin, Kihyuk
    Kim, Hoon-Soo
    Kim, Byungsoo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    Kim, Yun Hak
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : 52 - 61
  • [28] The effectiveness of Janus kinase inhibitors in treating atopic dermatitis: A systematic review and meta-analysis
    Arora, Charan Jeet
    Khattak, Fakhre Alam
    Yousafzai, Mohammad Tahir
    Ibitoye, Bukola Mary
    Shumack, Stephen
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [29] Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitors
    Jackson, J. Mark
    Althoff, Amanda
    Rasouliyan, Lawrence
    Long, Stacey
    Zema, Carla L.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1296 - 1298
  • [30] Emerging trends in clinical research on Janus kinase inhibitors for atopic dermatitis treatment
    Shih, Pei-Yun
    Li, Chia-Jung
    Yong, Su-Boon
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
12345